Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Oxidative stress and platelet hyperactivity: the role of NADPH oxidases in haemostasis regulation in health and diabetes.

Project description

Dissecting the molecular mechanism of thrombosis in diabetes

Type 2 diabetes (T2D) patients have a higher risk of developing cardiovascular disease, owing to the hyperactivity of platelets that lead to thrombosis. Researchers of the EU-funded POSTA project are working on NADPH oxidases (NOXs), enzymes that produce reactive oxygen and are implicated in various physiological processes. Recent evidence indicates that NOXs also activate platelets. Therefore, POSTA proposes to investigate the molecular mechanism by which NOX enzymes cause vascular complication in T2D. Apart from fundamental knowledge on platelet activation, project results may lead to novel interventions against T2D.

Objective

Platelets are circulating blood cells that help to arrest of bleeding (i.e. haemostasis) and promote the repair of blood vessels following injury. In type 2 diabetes mellitus (T2DM), platelets are hyperactive and their uncontrolled activation leads to the unwanted occlusion of blood vessels (i.e. thrombosis). Thrombosis is the main cause of mortality for T2DM patients, who display significantly higher risk of cardiovascular disease than the rest of the population. Currently, 70% of T2DM patients succumb to cardiovascular diseases.
I have been working on pro-oxidant enzymes called NADPH oxidases (NOXs), which are responsible for oxidative stress and activation of platelets. I have shown that the enzymatic activity of NOXs generates oxidant molecules (i.e. free radicals), which in turn are responsible for platelet activation. In preparation to this application, I have generated data showing that platelets from T2DM patients contain higher levels of the NOX1 isoform. This enzyme is responsible for oxidative stress and hyperactivity of platelets from T2DM platelets compared to healthy controls.
In this project, I aim to understand the molecular mechanisms underlying platelet regulation by NOXs and the contribution of NOX1 to platelet hyperactivity in T2DM. I will use human blood from T2DM patients and murine models of T2DM. In addition to clarifying the role of NOX1 in the vascular complications of T2DM, I will test whether NOX1 inhibitors synthesised in my laboratory can protect the health of the vascular system in this disease.
Taken together, this project will markedly advance our understanding of how platelets are regulated and will generate novel information on the link between cardiovascular risk and T2DM, which may result in a substantial improvement of the clinical management of this disease.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2020

See all projects funded under this call

Coordinator

UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF
Net EU contribution
€ 162 806,40
Address
Martinistrasse 52
20251 Hamburg
Germany
Region
Hamburg Hamburg Hamburg
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 162 806,40